Canadian Biopharma Stock Soars on COVID-19 Vaccine Update

IMV Inc. (TSX:IMV), a Canadian biopharma stock, jumped after announcing further details on its COVID-19 vaccine candidate

Sean Mason | July 14, 2020 | SmallCapPower

“Rapid progress” towards a COVID-19 vaccine candidate sparked a Canadian biopharma stock Tuesday. Here’s some small stocks making big moves on Tuesday, July 14, 2020 (as of 4 pm EST):

IMV Inc. (TSX:IMV), a Canadian biopharma stock, surged 57% to $6.35 on Tuesday after announcing further details on what the Company calls “rapid progress” in developing its candidate vaccine to prevent COVID-19 infection, which includes an agreement with Health Canada on a Phase 1 clinical study design protocol that also includes patients 56 years and older.

Win Big With Our Small Cap Picks

 

As well, shares of Calfrac Well Services Ltd. (TSX:CFW) fell 18% to $0.14 as the provider of specialized oilfield services said it has obtained a preliminary court order to restructure certain debt obligations, which would lead to a recapitalization transaction.

Pascal Biosciences Inc. (TSXV:PAS), meanwhile, reported that it has discovered certain cannabinoids that block replication of SARS-CoV-2, the coronavirus that causes COVID-19. Pascal Biosciences stock popped 26% to $0.315 following the announcement.

Finally, Northern Vertex Mining Corp. (TSXV:NEE) shares gained 6% to $0.37 after the junior precious metals miner announced record production of 11,365 gold equivalent ounces in addition to record revenue of US$18.2 million for the quarter ended June 30 from its 100% owned Moss Gold Mine in Arizona.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: